| 摘要 |
Disclosed is a method for evaluating renal status in a subject ex vivo, comprising: performing one or more assays configured to detect one or more biomarkers in a body fluid sample obtained previously from the subject to provide an assay result, wherein at least one of the markers is Stromelysin-1:Metalloproteinase inhibitor 2 complex; and correlating an assay result(s) to the renal status of the subject. |
